CRISPR Therapeutics and MaSTherCell SA sign service agreement for the development and manufacturing of … – GlobeNewswire (press release)
|
CRISPR Therapeutics and MaSTherCell SA sign service agreement for the development and manufacturing of …
GlobeNewswire (press release) BASEL, Switzerland and CAMBRIDGE, Mass. and GOSSELIES, Belgium, June 06, 2017 (GLOBE NEWSWIRE) — CRISPR Therapeutics AG (NASDAQ:CRSP), a leader in gene-editing based therapeutics, and MaSTherCell SA, a full service contract … |
